UNUM Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
UNUM Therapeutics Inc
TickerCOGT
CIK #0001622229
CUSIP19240Q201
SectorLife Sciences - Pharmaceutical Preparations
Address200 Cambridge Park Drive Suite 3100, Cambridge, MA 02140
Source [EDGAR]
CIK Filing 2011 - 2024
[0001622229] 10-K
[0001622229] 10-Q
[0001622229] 3
[0001622229] 4
[0001622229] 8-K
[0001622229] D
[0001622229] SC 13D
[0001622229] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Cogent Biosciences Inc [2023-06-01] 5.0
State Street Corp Cogent Biosciences Inc [2023-02-03] 6.1
BlackRock Inc Cogent Biosciences Inc [2023-02-03] 7.1
RA Capital Management LP Cogent Biosciences Inc [2022-09-06] 5.49
BlackRock Inc Cogent Biosciences Inc [2022-07-08] 3.8
Flynn James E Cogent Biosciences Inc [2022-06-17] 9.64
Frazier Life Sciences Public Fund LP Cogent Biosciences Inc [2022-03-01] 5.5
Eventide Asset Management LLC Cogent Biosciences Inc [2022-02-14] 8.8
Biotechnology Value Fund L P Cogent Biosciences Inc [2022-02-14] 4.2
Janus Henderson Group PLC Cogent Biosciences Inc [2022-02-11] 6.3
BlackRock Inc Cogent Biosciences Inc [2022-02-04] 6.8
Commodore Capital LP Cogent Biosciences Inc [2021-11-04] 5.4
TCG Crossover Management LLC Cogent Biosciences Inc [2021-07-08] 5.2
RTW Investments LP Cogent Biosciences Inc [2020-12-03] 0.99
Ally Bridge Group NY LLC Cogent Biosciences Inc [2020-11-19] 8.03
Logos Global Management LP UNUM Therapeutics Inc [2020-09-08] 5.0
Venrock Healthcare Capital Partners II LP UNUM Therapeutics Inc [2020-07-20] 5.0
Ridgeback Capital Investments LP UNUM Therapeutics Inc [2020-07-16] 6.2
Biotechnology Value Fund L P UNUM Therapeutics Inc [2020-07-16] 0.99
Fairmount Funds Management LLC UNUM Therapeutics Inc [2020-07-10] 19.99
New Leaf Ventures III LP UNUM Therapeutics Inc [2019-02-13] 3.0
Sanofi UNUM Therapeutics Inc [2019-02-11] 5.91
Atlas Venture Fund IX LP UNUM Therapeutics Inc [2019-02-08] 11.21
BlackRock Inc UNUM Therapeutics Inc [2019-02-08] 5.1
FMR LLC UNUM Therapeutics Inc [2018-04-05] 0.0
Form 3/4/5 Filer 2011 - 2024
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
Harwin Peter Evan
Shegog Todd
Ros Matthew
Morris Arlene
Cain Christopher W
Ferrante Karen Jean
Robinson John Edward
Kearns Evan
Sachs Jessica
Green John L.
Robbins Andrew R
Campana Dario
VHCP Co-Investment Holdings II, LLC
VHCP Management III, LLC
VHCP Co-Investment Holdings III, LLC
Venrock Healthcare Capital Partners II, L.P.
Venrock Healthcare Capital Partners III, L.P.
Koh Bong Y
VHCP Management II, LLC
Shah Nimish P
Booth Bruce
Aldag Jorn
Ettenberg Seth
Osborne Matthew Scott
Hodge Geoffrey
Perez Robert J
Ratcliffe Liam
Vasconcelles Michael
Wilson Charles
FIL Ltd
FMR LLC
Atlas Venture Associates IX, L.P.
Atlas Venture Fund IX, L.P.
Atlas Venture Associates IX, LLC
Stamoulis Christiana
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2023-03-31] SOLE 0.0 5,999,481.0
BlackRock Inc. [2023-03-31] SOLE 4,934,034.0 5,042,070.0
VR Adviser LLC [2023-03-31] SOLE 4,884,977.0 4,884,977.0
Commodore Capital LP [2023-03-31] SOLE 4,772,421.0 4,772,421.0
TCG Crossover Management LLC [2023-03-31] SOLE 3,631,042.0 3,631,042.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,447,512.0
State Street Corp [2023-03-31] DFND 3,360,014.0 3,427,714.0
Deerfield Management Company LP Series C [2023-03-31] DFND 2,966,345.0 2,966,345.0
Fairmount Funds Management LLC [2023-03-31] SOLE 2,758,975.0 2,758,975.0
Eventide Asset Management LLC [2023-03-31] SOLE 2,589,778.0 2,589,778.0
Perceptive Advisors LLC [2023-03-31] SOLE 2,282,324.0 2,282,324.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 2,236,700.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 2,159,154.0 2,159,154.0
Vivo Capital LLC [2023-03-31] SOLE 1,994,941.0 1,994,941.0
Suvretta Capital Management LLC [2023-03-31] SOLE 1,819,693.0 1,819,693.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,809,379.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 1,662,265.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 1,386,613.0 1,386,613.0
Geode Capital Management LLC [2023-03-31] DFND 1,318,308.0 1,318,308.0
Citadel Advisors LLC [2023-03-31] DFND 1,312,972.0 1,312,972.0
Logos Global Management LP [2023-03-31] SOLE 1,000,000.0 1,000,000.0
Farallon Capital Management LLC [2023-03-31] OTR 983,452.0 983,452.0
Candriam SCA [2023-03-31] SOLE 937,068.0 937,068.0
5AM Venture Management LLC [2023-03-31] SOLE 790,440.0 790,440.0
Walleye Capital LLC [2023-03-31] SOLE 786,596.0 786,596.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 709,693.0 786,430.0
Cormorant Asset Management LP [2023-03-31] DFND 700,000.0 700,000.0
Assenagon Asset Management S.A. [2023-03-31] SOLE 698,271.0 698,271.0
SilverArc Capital Management LLC [2023-03-31] SOLE 579,264.0 579,264.0
Goldman Sachs Group Inc [2023-03-31] DFND 553,690.0 553,730.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com